In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, MoonLake Immunotherapeutics (NASDAQ: MLTX) closed at $43.50 up 1.16% from its previous closing price of $43.00. In other words, the price has increased by $1.16 from its previous closing price. On the day, 0.41 million shares were traded. MLTX stock price reached its highest trading level at $44.195 during the session, while it also had its lowest trading level at $42.93.
Ratios:
For a deeper understanding of MoonLake Immunotherapeutics’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.11 and its Current Ratio is at 21.11. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.
On March 18, 2025, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $67.
Goldman Upgraded its Neutral to Buy on January 17, 2025, whereas the target price for the stock was revised from $62 to $82.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 04 ’24 when BVF PARTNERS L P/IL sold 2,000,000 shares for $50.00 per share. The transaction valued at 100,003,200 led to the insider holds 1,287,768 shares of the business.
Sturge Simon sold 171,000 shares of MLTX for $9,186,120 on Oct 04 ’24. The Director now owns 171,980 shares after completing the transaction at $53.72 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MLTX now has a Market Capitalization of 2761132032 and an Enterprise Value of 2361657088.
Stock Price History:
The Beta on a monthly basis for MLTX is 1.23, which has changed by 0.10154474 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, MLTX has reached a high of $58.26, while it has fallen to a 52-week low of $31.42. The 50-Day Moving Average of the stock is 7.80%, while the 200-Day Moving Average is calculated to be -4.43%.
Shares Statistics:
For the past three months, MLTX has traded an average of 530.99K shares per day and 593440 over the past ten days. A total of 63.47M shares are outstanding, with a floating share count of 52.94M. Insiders hold about 16.60% of the company’s shares, while institutions hold 94.66% stake in the company. Shares short for MLTX as of 1748563200 were 6312098 with a Short Ratio of 11.89, compared to 1745971200 on 6096506. Therefore, it implies a Short% of Shares Outstanding of 6312098 and a Short% of Float of 22.32.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
